Hiroshi Hamamoto

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 17

Top Topics

Antimicrobial Resistance

Pulmonary Tuberculosis

Helicobacter Pylori

Top Venues

The Journal of antibiotics

Scientific reports

Nature communications

Nature chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroshi Hamamoto
Silkworm model of bacterial infection facilitates the identification of lysocin E, a potent, ultra-rapid bactericidal antibiotic. The Journal of antibiotics 77 (8) (2024)
Hiroshi Hamamoto
Silkworm model of bacterial infection facilitates the identification of lysocin E, a potent, ultra-rapid bactericidal antibiotic. The Journal of antibiotics (2024)
Hiroshi Hamamoto
Silkworm model of bacterial infection facilitates the identification of lysocin E, a potent, ultra-rapid bactericidal antibiotic. The Journal of antibiotics 77 (8) (2024)
Hiroshi Hamamoto, Suresh Panthee, Atmika Paudel, Suguru Ohgi, Yutaka Suzuki, Koichi Makimura, Kazuhisa Sekimizu
Transcriptome change of Staphylococcus aureus in infected mouse liver. Communications biology 5 (1) (2022)
Atmika Paudel, Suresh Panthee, Hiroshi Hamamoto, Tom Grunert, Kazuhisa Sekimizu
YjbH regulates virulence genes expression and oxidative stress resistance in Staphylococcus aureus. Virulence 12 (1) (2021)
Hiroshi Hamamoto, Suresh Panthee, Kana Hashimoto, Toshio Tsuchida, Kazuhisa Sekimizu
An efficient method to screen for the soil bacteria producing therapeutically effective antibiotics. The Journal of antibiotics 74 (12) (2021)
Suresh Panthee, Hiroshi Hamamoto, Yayoi Nishiyama, Atmika Paudel, Kazuhisa Sekimizu
Novel Pathogenic Mucorales Identified Using the Silkworm Infection Model. Journal of fungi (Basel, Switzerland) 7 (11) (2021)
Hiroshi Hamamoto, Suresh Panthee, Atmika Paudel, Kenichi Ishii, Jyunichiro Yasukawa, Jie Su, Atsushi Miyashita, Hiroaki Itoh, Kotaro Tokumoto, Masayuki Inoue, Kazuhisa Sekimizu
Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus. Nature communications 12 (1) (2021)
Suresh Panthee, Naoko Kito, Teruo Hayashi, Takeshi Shimizu, Jun Ishikawa, Hiroshi Hamamoto, Hiroyuki Osada, Shunji Takahashi
β-carboline chemical signals induce reveromycin production through a LuxR family regulator in Streptomyces sp. SN-593. Scientific reports 10 (1) (2020)
Yuri Takada, Hiroaki Itoh, Atmika Paudel, Suresh Panthee, Hiroshi Hamamoto, Kazuhisa Sekimizu, Masayuki Inoue
Discovery of gramicidin A analogues with altered activities by multidimensional screening of a one-bead-one-compound library. Nature communications 11 (1) (2020)
Kanji Hosoda, Nobuhiro Koyama, Hiroshi Hamamoto, Akiho Yagi, Ryuji Uchida, Akihiko Kanamoto, Hiroshi Tomoda
Evaluation of Anti-Mycobacterial Compounds in a Silkworm Infection Model with Mycobacteroides abscessus. Molecules (Basel, Switzerland) 25 (21) (2020)
Hiroaki Itoh, Kotaro Tokumoto, Takuya Kaji, Atmika Paudel, Suresh Panthee, Hiroshi Hamamoto, Kazuhisa Sekimizu, Masayuki Inoue
Development of a high-throughput strategy for discovery of potent analogues of antibiotic lysocin E. Nature communications 10 (1) (2019)
Atmika Paudel, Suresh Panthee, Hiroshi Hamamoto, Kazuhisa Sekimizu
GPI0363 inhibits the interaction of RNA polymerase with DNA in Staphylococcus aureus . RSC advances 9 (65) (2019)
Hiroshi Hamamoto, Ryo Horie, Kazuhisa Sekimizu
Pharmacokinetics of anti-infectious reagents in silkworms. Scientific reports 9 (1) (2019)
Atmika Paudel, Suresh Panthee, Makoto Urai, Hiroshi Hamamoto, Tomohiko Ohwada, Kazuhisa Sekimizu
Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model. Scientific reports 8 (1) (2018)
Akiho Yagi, Ryuji Uchida, Hiroshi Hamamoto, Kazuhisa Sekimizu, Ken-Ichi Kimura, Hiroshi Tomoda
Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis. The Journal of antibiotics 70 (5) (2017)
Jie Su, Maki Iehara, Jyunichiro Yasukawa, Yasuhiko Matsumoto, Hiroshi Hamamoto, Kazuhisa Sekimizu
A novel mutation in the vraS gene of Staphylococcus aureus contributes to reduce susceptibility against daptomycin. The Journal of antibiotics 68 (10) (2015)
Hiroshi Hamamoto, Makoto Urai, Kenichi Ishii, Jyunichiro Yasukawa, Atmika Paudel, Motoki Murai, Takuya Kaji, Takefumi Kuranaga, Kenji Hamase, Takashi Katsu, Jie Su, Tatsuo Adachi, Ryuji Uchida, Hiroshi Tomoda, Maki Yamada, Manabu Souma, Hiroki Kurihara, Masayuki Inoue, Kazuhisa Sekimizu
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nature chemical biology 11 (2) (2014)